3 Apr 2018 16:03
UK Earnings, Trading Statements Calendar - Next 7 Days
Wednesday 4 April RenewiTrading statementNext Fifteen Communications GroupFull Year 5 (at
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
LID.L Share News (LID)
LID Share
Price
LID Share
News
LID Share
Chat
LID Share
Trades
LID
Live RNS
LID Share
Charts
LID Broker
Ratings
LID Directors
Deals
LID Financial
Diary
LID
Fundamentals
LID Short
Positions
LID
Media
LID.L Information
- There is currently no data for LID
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.LiDCO receives approval from FDA
Wed, 04th Sep 2013 10:35
LiDCO, a cardiovascular monitoring company, said Wednesday that the US Food and Drug Administration (FDA) has cleared its CNSystems' continuous non-invasive blood pressure monitoring module for sale. The software enables the connection of modules to the LiDCOrapid cardiac output monitor allowing it to co-display the blood pressure reading with Covidien's depth of anaesthesia parameter. The company said it believes there is growing demand for a multi-parameter monitor display which can reduce the number of single parameter monitors by the patient bedside.It estimated that 3.4m patients would be suitable for peri-operative hemodynamic monitoring in the US alone and believes that with the FDA clearance the commercial opportunity to build its presence in the States is "substantial". LiDCO received CE marking for sales in Europe of the LiDCOrapid with both modules in February 2013 and FDA clearance for the LiDCOrapid with the depth of anaesthesia parameter in March 2013.Chief Executive Terry O'Brien said: "I am delighted we have met this key milestone in our strategy for expanding our presence in the US intraoperative fluid monitoring market. "This approval has increased LiDCO's market opportunity considerably and we expect that by further increasing the breadth of monitoring displayed on the LiDCOrapid we will make our products more attractive, particularly in response to an increasing requirement within hospitals to move towards multi parameter monitors."NR
More News
14 Feb 2017 12:46
LiDCO posts extensive trading update
(ShareCast News) - Cardiovascular monitoring company LiDCO Group provided a trading update for the full year to 31 January on Tuesday, with product revenues in the period expected to be up 14% to £6.76m, with total revenues - including third party products - expected to be up by 8% to £8.21m. The AI
Read more14 Feb 2017 09:11
10 Jan 2017 11:50
LiDCO appoints Shane Doorish as head of North America
(ShareCast News) - Hemodynamic monitoring company LiDCO announced the appointment of Shane Doorish as head of North America on Tuesday, with immediate effect. The AIM-traded firm said Doorish was bringing with him 19 years of experience in the healthcare sector having originally trained as a critica
Read more16 Dec 2016 16:10
11 Oct 2016 11:37
LiDCO narrows loss in first half
(ShareCast News) - Hemodynamic monitoring company LiDCO announced its unaudited interim results for the six months to 31 July on Tuesday, with product revenues up 10% to £3.03m. The AIM-traded firm's total product revenues, including third party products, was up 5% to £3.77m, with US revenues up 37%
Read more18 May 2016 15:05
16 May 2016 14:18
Lidco inks US distribution deal with ICU Medical
(ShareCast News) - LiDCO has inked a distribution agreement with partner ICU Medical to sell the LiDCO IM non-invasive hemodynamic monitoring system in the US. LiDCO IM is a specially configured hemodynamic monitor produced exclusively for ICU Medical. It works solely in conjunction with LiDCO's non
Read more21 Apr 2016 16:38
LiDCO shows off new hemodynamic monitoring tech
(ShareCast News) - Hemodynamic monitoring company LiDCO was busy in the US capital this week, showing off its new technology LiDCOunity monitor at the 2016 Annual Congress of Advanced Recovery and Perioperative Medicine. The conference is currently being held in Washington, D.C. LiDCO's board said
Read more